Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
|
|
CASI Pharmaceuticals, Inc (DE) (CASI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 6.6% stake in CASI PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| Consonance Capital Management LP reports a 0% stake in CASI PHARMACEUTICALS INC |
| 02/14/2022 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 7.3% stake in CASI PHARMACEUTICALS, INC. |
| 02/19/2020 |
SC 13G/A
| Wealth Strategy Holding Ltd reports a 10.9% stake in § 240.13d-2 CASI Pharmaceuticals, Inc |
| 02/06/2019 |
SC 13G/A
| Zhejiang Kanglaite Group Co., LTD reports a 0% stake in CASI Pharmaceuticals, Inc. |
| 10/11/2018 |
SC 13G/A
| Wealth Strategy Holding Ltd reports a 10.7% stake in § 240.13d-2 CASI Pharmaceuticals, Inc |
| 03/03/2017 |
SC 13G/A
| Zhejiang Kanglaite Group Co., LTD reports a 8.1% stake in CASI Pharmaceuticals, Inc |
| 02/14/2011 |
SC 13G/A
| ENTREMED INC reports a 0% stake in EntreMed, Inc. |
| 02/07/2007 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2006 |
SC 13G/A
| EDELMAN JOSEPH reports a 0.4% stake in Entremed, Inc. |
| 02/11/2005 |
SC 13G/A
| SMITHFIELD FIDUCIARY LLC reports a 1.9% stake in EntreMed, Inc. |
| 02/17/2004 |
SC 13G/A
| MILLENNIUM PARTNERS, L.P. reports a 3.8% stake in EntreMed, Inc. |
| 01/10/2003 |
SC 13G/A
| FMR CORP reports a 1.5% stake in EntreMed Incorporated |
| 02/14/2002 |
SC 13G/A
| FMR CORP reports a 6.7% stake in EntreMed Incorporated |
| 02/11/2000 |
SC 13G/A
| BRISTOL MYERS SQUIBB CO reports a 4% stake in EntreMed, Inc. |
| 10/29/1998 |
SC 13G/A
| DAVIS J MORTON reports a 4.7% stake in EntreMed, Inc. |
| 02/06/1998 |
SC 13G/A
| DAVIS J MORTON reports a 8.4% stake in EntreMed, Inc. |
|
|